Human-relevanT 3D vascularized tissue platforms for predictive drug discovery
We engineer perfusable, high-density human tissues that replicate native microenvironments—enabling more accurate drug screening, disease modeling, and therapeutic development.
Problem
Drug discovery pipelines rely on models that fail to reproduce human physiology.
Over 90% of drug candidates fail in clinical trials
2D cultures and spheroids lack vascularization
Poor prediction of drug penetration, efficacy, and toxicity
Our Solution
Elevation Biosciences develops vascularized 3D tissue platforms that bridge the gap between in vitro models and human biology.
Our proprietary Nexus 3D technology integrates:
Perfusable microvascular networks
High cell-density engineered tissues
Tunable biomimetic hydrogels
TECHNOLOGY SNAPSHOT
Nexus 3D Platform
A scalable platform for engineering functional, vascularized human tissues.
Embedded perfusable vascular networks
Physiologically relevant transport gradients
High-throughput compatibility
Compatible with multiple tissue types (oncology, cardiac, fibrotic tissues)
APPLICATIONS
For Pharmaceutical & Biotech Companies
Drug efficacy and penetration testing
Combination therapy optimization
Predictive toxicity screening
For Translational Research
Disease modeling (cancer, fibrosis, cardiovascular)
Mechanobiology and microenvironment studies
For Precision Medicine
Patient-specific tissue models
Therapy response prediction
WHY ELEVATION BIOSCIENCES
Vascularization-first approach (key differentiator)
Scalable and reproducible platform
Bridges academic innovation and pharma application
Designed for translational impact